This is the cause of the rare thrombi related to AstraZeneca and Janssen

A team of experts from the Goethe University in Frankfurt has found the cause of the rare blood clots that have appeared after the administration of the AstraZeneca and Janssen vaccines. According to information published by the Financial Times, they could have found the main problem that generates these side effects, if their theory is correct, the current vaccine could be modified to avoid this type of ailment that can end in tragedy. This study could kill rare blood clots related to AstraZeneca and Janssen AstraZeneca and Janssen: This is the cause of rare blood clots Goethe University professor and research leader Rolf Marschalek has found the main key to this ‘mistake’ AstraZeneca and Janssen vaccine, it is the case that both are created in the same way. According to this expert, the adenovirus vectors that are used to deliver the SARS-CoV-2 spike protein into the body are the cause of rare thrombi. Once these vectors fulfill their mission, certain parts of the spike protein they splice or separate, creating mutant versions, which cannot bind to the cell membrane where significant immunization takes place. By being left out of this system, they end up causing blood clots in 1 in 100,000 people, which in very serious cases can cause death. This happens because the genetic material does not enter the cell, it remains outside and is joins it creating immunity. There is a possibility, According to Marschalek, to avoid this effect, if the sequence of the peak protein can be modified to prevent it from separating, it will fulfill its function within the cell without ending up creating the dangerous thrombi.Continuing with this study, the American pharmaceutical company that makes Janseen is trying to modify the system to make it safer by following the guidelines of the German experts who have analyzed its vaccine. AstraZeneca, on the other hand, has not contacted Marschelek to get their vaccine modified thanks to the discovery of this team. With these data, we know a little better how the vaccine works in some people, although they are all safe, these thrombi have appeared after being administered en masse in the world population. The recently published German study opens the door to ending these rare side effects shortly.